DNA Delivery Platform
Efficient, targeted, and safe non-viral systems for transporting genetic materials to cells and tissues.
Overview
Our DNA Delivery Platform is dedicated to developing and refining next-generation delivery systems that enable efficient, targeted, and safe transport of genetic materials. The focus is on identifying and optimizing delivery agents that achieve enhanced DNA uptake and expression while maintaining low toxicity and minimal immunogenicity.
By integrating advanced formulation science with molecular engineering, Vaxonyx aims to create versatile non-viral delivery platforms suitable for vaccines, gene therapy, and immunotherapy applications — ensuring reliable and reproducible performance across preclinical and translational studies.
Vaxonyx is actively seeking partnerships and collaborations to co-develop and validate novel DNA delivery technologies that can advance the next generation of genetic medicines.
Core capabilities
- High-efficiency DNA uptake with tunable release kinetics
- Targeted delivery strategies with minimal off-target exposure
- Low toxicity and minimal immunogenicity profiles
- Formulation–payload compatibility for plasmids and complex cargos
- Robust, reproducible performance from in vitro through translational studies
Collaborate with us
We welcome co-development programs to accelerate novel delivery technologies from concept to proof-of-concept and beyond.